
51 - 200 employees
Founded 2013
🏥 Healthcare
🏭 Manufacturing
⚕️ Healthcare Insurance
Healthcare • Manufacturing • Healthcare Insurance
Profound Medical Inc. is a leader in developing customizable, incision-free therapies for prostate diseases. The company specializes in transurethral ultrasound ablation (TULSA) technology, providing a patient-centric, MRI-guided procedure that ensures precise and accurate treatment. This innovative technology is CE marked, Health Canada approved, and FDA cleared in the U. S. , demonstrating a strong commitment to safety and efficacy in treating localized prostate cancer and other prostate disease states. With over 67 peer-reviewed publications and 5-year clinical outcomes, Profound Medical emphasizes durable treatment results and patient well-being. Their TULSA procedure uses real-time MRI temperature monitoring, enabling precise tissue ablation and ensuring patient safety while treating a range of prostate conditions.
🕒 October 30
Where this job comes from
Posted on Profound Medical Inc.'s careers page, not through a job board
First seen by Remote Rocketship October 30
Still open on Profound Medical Inc.'s site. Checked 3 hours ago.

51 - 200 employees
Founded 2013
🏥 Healthcare
🏭 Manufacturing
⚕️ Healthcare Insurance
Healthcare • Manufacturing • Healthcare Insurance
Profound Medical Inc. is a leader in developing customizable, incision-free therapies for prostate diseases. The company specializes in transurethral ultrasound ablation (TULSA) technology, providing a patient-centric, MRI-guided procedure that ensures precise and accurate treatment. This innovative technology is CE marked, Health Canada approved, and FDA cleared in the U. S. , demonstrating a strong commitment to safety and efficacy in treating localized prostate cancer and other prostate disease states. With over 67 peer-reviewed publications and 5-year clinical outcomes, Profound Medical emphasizes durable treatment results and patient well-being. Their TULSA procedure uses real-time MRI temperature monitoring, enabling precise tissue ablation and ensuring patient safety while treating a range of prostate conditions.
• Lead a regional team of Program Development Managers and own TULSA-PRO Procedure growth across the region • Hire, train and develop Program Development Managers • Build clinical champions, grow installed programs and deliver against quota • Deliver TULSA-PRO Procedure growth against regional quota • Recruit, hire and onboard top PDM talent • Train and develop PDMs using the PDM Competency Rubric, field coaching and regular performance reviews • Spend the majority of time in the field with PDMs through rides, account planning, QBRs and key customer meetings • Build the regional business plan and set territory quotas and priorities with the VP of US Sales • Review PDM account and territory plans and hold the team accountable • Manage performance, recognize top performers, coach to the standard and address underperformance • Engage senior hospital and IDN leaders in priority accounts to win program priority and resources • Partner with the Regional Business Director and Capital Sales Executives to align capital and program growth strategy • Work with Clinical, Marketing, Market Access, Clinical Scientists and Service to remove regional barriers to growth • Run the regional business rhythm, including forecasting, pipeline, CRM, budget, expenses and reporting to the VP of US Sales • Ensure adherence to regulatory requirements, the AdvaMed Code of Ethics, internal SOPs and Profound Medical policies
• Minimum Bachelor’s degree or equivalent experience required • 8+ years of medical device sales experience • 3+ years of sales leadership experience • Documented record of team quota attainment • Proven record of hiring, training and developing sales talent, including promotions from within the team • Proven documented success growing procedure volume or utilization across an installed base • Capital-plus-procedure, robotic, novel or image-guided therapy sales leadership experience strongly preferred • Experience with Class II/III medical devices preferred • Familiarity with urology, radiology or oncology clinical environments preferred • Experience building relationships with hospital executives and IDN / health system leaders • Strong business planning, forecasting and analytical skills • Excellent communication, presentation and coaching skills • Proficiency in CRM tools, Excel and PowerPoint • Candidate may be based in the surrounding East region, including neighboring states, provided they are located near a major airport
• Diversity and equal opportunity workplace • Reasonable accommodation support during recruitment, selection, and/or assessment processes
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 October 30
Program Director leading mainframe optimization, transformation, and delivery programs for Ensono, a managed technology services provider. Advising clients, managing P&L, and supporting pre-sales solutioning.
🇺🇸 United States – Remote
💵 $135k - $205k / year
⏰ Full Time
🔴 Lead
📋 Program Manager
🦅 H1B Visa Sponsor
🕒 October 30
Real estate program manager leading Flexential’s data center portfolio strategy, transactions, and complex cross-functional initiatives. Managing financial analysis, risks, budgets, and executive stakeholder alignment.
🕒 October 30
Program Manager leading Fairwinds Technologies’ multinational NATO SATCOM defense program. Managing integration, deployment, sustainment, contracts, risks, and cross-functional teams.
🕒 October 30
Director managing MGA member relationships, onboarding, communications, and operations for Bishop Street Underwriters. Coordinating insurance teams, resolving issues, and improving program engagement and performance.
🇺🇸 United States – Remote
💵 $150k - $200k / year
🔥 Funding within the last year
💰 $125M Corporate Round on 2026-02
⏰ Full Time
🔴 Lead
📋 Program Manager
🕒 October 30
Director of Program Management leading integrated plans, regulatory submissions, and launch readiness. Advancing rare-disease therapies at biopharmaceutical company Quetzal Therapeutics.